Article
Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy.
Cancer research - 15 Aug 2011
Yang Fei, Tang Ximing, Riquelme Erick, Behrens Carmen, Nilsson Monique B, Giri Uma, Varella-Garcia Marileila, Byers Lauren A, Lin Heather Y, Wang Jing, Raso Maria G, Girard Luc, Coombes Kevin, Lee J Jack, Herbst Roy S, Minna John D, Heymach John V, Wistuba Ignacio I
Abstract excerpt
VEGF receptor-2 (VEGFR-2 or kinase insert domain receptor; KDR) is a known endothelial target also expressed in NSCLC tumor cells. We investigated the association between alterations in the KDR gene and clinical outcome in patients with resected non-small-cell lung carcinoma (NSCLC; n = 248). KDR copy number gains (CNG), measured by quantitative PCR and fluorescence in situ hybridization, were detected in 32% of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
